Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Short SellingSee which listed companies have disclosed short interest
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

I-tech

60.50 SEK+0.17 %19/11 17:27
Less than 1K followers

ITECH

First North Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Short Selling
Investor views
Compare
+0.17 %
-1.94 %
-14.91 %
-3.97 %
+15.90 %
-6.92 %
+35.96 %
-13.07 %
+145.29 %

I-tech operates in marine technology. The company conducts research and development of substances that inhibit marine fouling on ship hulls. In addition, the products can be used for various marine installations in fish farming and offshore. Customers are found in the marine paint industry and among other players in the shipping industry. I-Tech was founded in 2000 and has its headquarters in Mölndal.

Read more
Market cap
725.87M SEK
Turnover
1.03M SEK
Revenue
168.12M
EBIT %
24.41 %
P/E
21.61
Dividend yield-%
2.07 %
Revenue and EBIT-%
EPS and dividend
Financial calendar
All
Press releases
3rd party
ShowingAll content types

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
4/2
2027

Annual report '26

6/5
2027

Interim report Q1'27

20/8
2027

Interim report Q2'27

Press release2026-11-18 10:00

I-Techs valberedning utsedd

I-tech
Press release2026-11-18 10:00

I-Tech's Nomination Committee appointed

I-tech
Press release2026-11-03 16:41

Redeye: I-Tech: EU vote as expected

I-tech

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
Followings and notifications on followed companies
PREMIUM account
All company reports and deep analyses
Premium tools: model portfolio, screener, insider transactions
Premium columns: Guest column, expert insights
Inderes MCP - Inderes data directly into your AI tools
Create account
Third party research2026-11-03 14:39

I-tech: EU votes for non-renewal of Selektope - ABG

* EU member states back non-renewal of Selektope approval * Limited impact on near-term financials; EU ~4% of sales * Still positive on long-term prospects, but spill-over risk remains The decision and next steps I-Tech announced this afternoon that ...

I-tech
Regulatory press release2026-11-03 14:10

EU-länderna stöder förslag om att inte förnya godkännandet av Selektope – begränsad påverkan på verksamheten väntas

I-tech
Regulatory press release2026-11-03 14:10

EU Member States support non-renewal of Selektope approval; limited commercial impact expected

I-tech
Press release2026-10-21 12:59

Redeye: I-Tech (Q3 Review): Navigating EU-BPR With a Strong Core

I-tech
Third party research2026-10-19 08:30

I-tech: Order timing weighs but growth intact - ABG

* Q3 sales -9%, EBIT -20% vs. ABGSCe on timing and tech costs * We lower ‘26e-‘28e sales by 3% and EBIT adj. by 4%/6%/5% * EU vote outcome expected within a few weeks Q3 affected by order timing and technology costs Q3 sales were SEK 49m (-9% vs. ABGSCe...

I-tech
Press release2026-10-16 08:47

Investor Studios: Ledningen i I-Tech presenterar kvartalet live 13.00

I-tech
Third party research2026-10-16 08:44

I-tech: Solid growth but technology costs weigh - ABG

Sales -9% vs. ABGSCe, EBIT SEK 13m vs. ABGSCe 17m * Organic growth of 18%, strong gross margin 60% (57% LY) * We estimate opex includes ~SEK 2m for acquired and licensed tech Q3 results Sales came in at SEK 49m (-9% vs. ABGSCe 54m), +19% y-o-y (+18% ...

I-tech
Regulatory press release2026-10-16 08:00

I-Tech AB (publ) (ticker ITECH) publicerar härmed sin delårsrapport för Q3 2026

I-tech
Regulatory press release2026-10-16 08:00

I-Tech AB (publ) (ticker: ITECH) publish the interim report Q3 for 2026

I-tech
Press release2026-10-15 16:36

Redeye: I-Tech: Signs Aquaculture license agreement

I-tech
Press release2026-10-15 09:30

I-Tech ingår exklusivt licensavtal för akvakultur med Titanium Technology

I-tech
Press release2026-10-15 09:30

I-Tech enters exclusive aquaculture licence agreement with Titanium Technology

I-tech
Third party research2026-10-13 07:09

I-tech: Expecting broad-based growth - ABG

* Q3e: +29% organic growth, EBIT SEK 17m (11m) * '27e-'28e adj. EBIT raised by 6-8% on FX * EU vote ahead; '27e/'28e EV/EBIT of 6x/4x, ~60-80% below peers Q3 expectations We estimate Q3 sales of SEK 54m, +31% y-o-y (+29% org., +2% FX). We expect growth...

I-tech
Press release2026-08-24 12:11

Redeye: I-Tech (Q2 Review): Strong execution and momentum

I-tech
Third party research2026-08-24 08:22

I-tech: Beyond a single molecule - ABG

* Q2 organic growth of +91% marks a record quarter * We raise '26e-'28e sales by 7% and EBIT by 23%, 13% & 9% * New aquaculture market entered; EU vote still pending Record quarter, easy comps aside I-Tech delivered very strong Q2 results, with 91% organic...

I-tech
Press release2026-08-21 10:16

Investor Studios: Ledningen i I-Tech presenterar kvartalet live 13.00

I-tech
Third party research2026-08-21 09:22

I-tech: Strongest quarter on record - ABG

Sales +21% vs. ABGSCe, EBIT SEK 21m vs. ABGSCe 13m Easy comps, but +91% organic growth still very strong Gross margin held at 59%; raw-material pressure mitigated so far Q2 results I-tech reported very strong Q2 numbers. Sales came in at SEK 59m (+21...

I-tech